Fig. 2: Best percentage change in the size of metastasis and best response in patients. | British Journal of Cancer

Fig. 2: Best percentage change in the size of metastasis and best response in patients.

From: The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon

Fig. 2

a–f show the waterfall plots of the best percentage change in the size of target lesions in each patient from the six groups. The analysis is based on Response Evaluation Criteria in Solid Tumours, version 1.1 (RECIST 1.1). The dashed lines at 20% and −30% represent progressive disease and partial response. The line at 0% means either no changes in metastatic sites or the development of a new lesion. g shows the tumour response in patients in different groups and is also evaluated based on RECIST 1.1. n number, ORR overall response rate, DCR disease control rate.

Back to article page